Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kronos Bio Inc | KRON | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.04 | 06:49:34 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.04 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.731 - 2.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.04 | USD |
Kronos Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 60.65M | 58.32M | - | 6.29M | -112.67M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kronos Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KRON Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.12 | 1.21 | 1.02 | 1.11 | 212,536 | -0.08 | -7.14% |
| 1 Month | 1.22 | 1.38 | 1.02 | 1.20 | 193,608 | -0.18 | -14.75% |
| 3 Months | 1.24 | 1.40 | 1.00 | 1.15 | 290,674 | -0.20 | -16.13% |
| 6 Months | 0.901 | 1.5053 | 0.731 | 1.12 | 250,765 | 0.139 | 15.43% |
| 1 Year | 1.39 | 2.29 | 0.731 | 1.35 | 275,081 | -0.35 | -25.18% |
| 3 Years | 21.57 | 28.42 | 0.731 | 6.80 | 286,145 | -20.53 | -95.18% |
| 5 Years | 28.29 | 39.605 | 0.731 | 9.70 | 278,268 | -27.25 | -96.32% |
Kronos Bio Description
| Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. |
